Recount of FOURIER Information Finds Greater Mortality With Evolocumab
Readjudication of mortality information from the FOURIER trial suggests the next danger for cardiovascular loss of life with evolocumab (Repatha)...
Readjudication of mortality information from the FOURIER trial suggests the next danger for cardiovascular loss of life with evolocumab (Repatha)...